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A B S T R A C T  
Background: Caralluma tuberculata, is a wild herb, which grows in the hills of Balochistan and has been known to have medicinal 
and nutritional properties since antiquity. This experimental research was designed to study the hypoglycemic properties of 
Caralluma tuberculata and to compare them with Metformin. 
Material and Methods: This was a laboratory-based animal experimental study. It was conducted in the Pharmacology laboratory 
of Khyber Medical University, Peshawar from February 2016 to August 2016. Two types of extracts of Caralluma tuberculata [crude 
extract and carbon tetrachloride (CCl4) extract] were prepared and administered to normal and alloxan treated diabetic rabbits. To 
study anti-diabetic activity, eighty-four rabbits were divided into two main groups. Group I (Normal/Non-Diabetic Rabbits; n= 21) and 
Group II (Diabetic/Alloxanized Rabbits; n=63).  Each group was further divided into sub-groups (7 rabbits in each).  Effect of 
Caralluma tuberculata, Metformin and 2% gum tragacanth on blood glucose levels were checked at 0, 2, 4, 6, 8, 12 and 24 hours of 
drug administration. The extracts were given in capsule form and in cooking oil. Data analysis was done using SPSS version 16. For 
calculation and comparison of the hypoglycemic effects at various doses and different time intervals, analysis of variance (ANOVA) 
and Tukey’s post hoc test were applied. 
Results: The crude extract, 200mg/kg body weight of Caralluma tuberculata showed significant decrease (p<0.001) in mean blood 
glucose levels from 2-hour till12 hours. Whereas, highly significant reduction of blood glucose was seen from 2 hours after treatment 
till 24 hours, when carbon tetrachloride (CCl4) fraction of Caralluma (100mg/kg body weight) in capsule form was administered. 
Metformin 500mg/kg body weight was given to compare its effects with plant crude extract and it was found that metformin appeared 
to be less effective in comparison with Caralluma tuberculata. 
Conclusion: Caralluma tuberculata lowered the blood glucose level and turned out to be more significant in developing 
hypoglycemia when taken with cooking oil. More work is essential to provide stronger evidence for the use of this natural agent in the 
management of Diabetes Mellites. 
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I n t r o d u c t i o n  
 
Diabetes mellitus is one of the most common metabolic 
disorders which occur either due to insufficient insulin 
release (Type 1 diabetes) or tissue resistance to insulin 
(Type 2 diabetes). There were around 382 million diabetic 
patients in the year 2013, and it is estimated that this 
figure is going to flare up to 592 million by 2035. Most of 
ORIGINAL ARTICLE 
                           J Islamabad Med Dental Coll 2019 35 
the diabetic patients reside in lower to middle developed 
countries.1 Prevalence of diabetes in rural areas of 
Pakistan constitutes 7% and 2.5% for men and women 
respectively, while in urban areas this figure is about 6% 
for men and 3% for women. According to another study, 
the glucose intolerance in urban areas is 14.2% for 
women and 6.3% for men versus 10.9% for women and 
6.9% for men in rural areas.2 
 
There are many plants which have been reported due to 
their traditional use as anti-diabetic agents, like 
momordica charantia, citrullus colocynthis, allium sativum, 
opuntia, aloe and artemisia.3,4 In many Indian traditional 
approaches like Ayurveda, about 800 different medicinal 
plants have been identified to have hypoglycemic activity, 
but very few of them got scientific scrutiny.5 Valuable 
information is available about phytochemical components 
responsible for hypoglycemic effect. The isolation of 
glycans from plant families such as, granmineae, 
ranunculaceae and extraction of glycosides from 
scrophulariaceae, rhamnaceae, caesalpiniaceae and 
papaveraceae are good examples of this. Moreover, 
some triterpenes from ranunculaceae, saponins of 
malvaceae and alkaloids of apocyanaceae have been 
reported for their hypoglycemic effect.6,7 However, the 
search for newer plants with anti-diabetic activity is still in 
progress. 
 
Caralluma tuberculata, which belongs to family 
Asclepiadaceae is a wild herb, grows in most of the hilly 
areas of Balochistan and is used as a vegetable since 
centuries. Caralluma species have been used by humans 
as tonic, carminative, anti-helminthic and anti-tumor 
agent.8 Caralluma is reported to be effective in 
rheumatism and also known to have hypotensive 
effect.9,10 The phytochemical constituents include volatile 
alkaloids, cardiac glycosides, flavonoids, saponins, sterols 
and tannins.11 Adnanet al reported that Caralluma when 
hydrolyzed under mild conditions gives cymarose, 
sarmentose, oleandrose or digitoxose as sugar 
component while work of Bashir et al  identified its various 
nutritional aspects and composition.12, 13 
 
This study was an attempt first to evaluate the 
hypoglycemic activity of crude and carbon tetrachloride 
(CCl4) extracts of Caralluma tuberculata and then to 
compare this hypoglycemic activity with metformin. 
M a t e r i a l  a n d  M e t h o d s  
This experimental study was carried out at the 
Department of Pharmacology, Khyber Medical University, 
Peshawar from February 2016 to August 2016. 
Institutional approval was obtained and all the ethical 
issues pertaining to animal pain and distress, feeding, 
caging etc. were addressed according to standard 
protocols for animal studies. Healthy male rabbits 
weighing 1 kg to 1.5 kg of Oryctologus cunniculus species 
were selected and kept in animal house for one week 
under strict observation where they were fed upon clean 
water and fresh fodder. To induce diabetes in normal 
rabbits, Alloxan monohydrate was injected in a dose of 
150 mg/kg body weight using tuberculin syringe. A week 
later, blood levels of glucose were determined by glucose 
oxidase method and only those rabbits were included in 
the study whose blood glucose level was in the range 
300-500mg/100ml.14,15 To study anti-diabetic activity, 
eighty-four rabbits were divided into two main groups. 
Group I (Normal/Non-Diabetic Rabbits; n= 21) and Group 
II (Diabetic/Alloxanized Rabbits; n=63).  Each group was 
further divided into sub-groups (7 rabbits in each, as the 
minimum number in each group is 6 in already 
established protocols).15 
 
Group 1 (n=21) was further subdivided into following 3 
subgroups: 
Subgroup A1: Treated with crude extract of Caralluma 
tuberculata 200 mg/kg body weight. 
Subgroup B1: Treated with Metformin 500 mg/kg body 
weight. 
Subgroup C1: Serving as control receiving 20 ml 2% gum 
tragacanth solution. 
Group II (n=63) was further divided into following 9 sub-
groups: 
Subgroup A2: Treated with crude extract of Caralluma 
tuberculata 200 mg/kg body weight (capsule form). 
Subgroup B2: Treated with Metformin 500 mg/kg body 
weight. 
Subgroup C2: Serving as control receiving 20 ml 2% gum 
tragacanth solution. 
Subgroup A3: Treated with CCl4 of Caralluma tuberculata 
100 mg/kg body weight (capsule form). 
Subgroup B3: Treated with Metformin 500 mg/kg body 
weight. 
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Subgroup C3: Serving as control receiving 20 ml 2% gum 
tragacanth solution. 
Subgroup A4: Treated with CCl4 of Caralluma tuberculata 
100 mg/kg body weight (in cooking oil). 
Subgroup B4: Treated with Metformin 500 mg/kg body 
weight. 
Subgroup C4: Serving as control receiving 20 ml soy 
bean cooking oil. 
 
The aerial part of the plant was washed and air dried. The 
dried material was grinded, passed through a mesh and 
put in distilled water at room temperature for several days, 
followed by squeezing in a muslin cloth. This procedure 
was repeated thrice, which as a result produced green 
syrupy residue. Fractionation of crude extract of 
Caralluma tuberculata was carried out by suspending the 
crude extract in water, partitioned with carbon 
tetrachloride (CCl4) by vigorous shaking in a separating 
funnel. The CCl4 layer was separated and evaporated 
under reduced pressure in rotary evaporator. The 
resultant residue was then treated with methanol. The 
methanol soluble fraction was separated from the 
insoluble (water soluble) material and evaporated in rotary 
evaporator. 
 
Effect of Caralluma tuberculata, Metformin and 2% gum 
tragacanth on blood glucose levels were checked at 0, 2, 
4, 6, 8, 12 and 24 hours of drug administration. 
 
Data analysis was done using SPSS version 16 and 
expressed as Mean ± SD. For calculation and 
comparison of the hypoglycemic effects at various doses 
& different time intervals, analysis of variance (ANOVA) 
and Tukey’s post hoc test were applied. 
 
R e s u l t s  
In non-diabetic group, treatment with crude extract of 
Caralluma produced significant reduction in mean blood 
glucose levels at 2 hours (p<0.001), 4 hours (p<0.001) 8 
hours (p<0.001) and 12 hours, but gradual increase in 
blood glucose levels was seen at 24 hours as compared 
to that at 12 hours interval (p<0.001). However, with 
metformin, the blood glucose levels decreased after 2 and 
4-hours interval but they started increasing from 8 to 24 
hours interval after treatment. This increase was 
significantly high as compared to that at 12 hours interval 
(p<0.01). Oral administration of 20 ml 2% gum tragacanth 
suspension did not produce any appreciable decrease in 
blood glucose level (Table I). 
When capsule form of Caralluma crude extract was given, 
significant reduction in blood glucose levels were 
observed at 2, 4, 8, 12- and 24-hours interval (p<0.001) 
as compared to that at zero hour (p>0.1) (Table II). 
Compared to 2 hours interval, there was no significant 
decrease in blood glucose levels at 4 hours interval 
(p=0.2) and 8 hours interval (p=0.2). There was significant 
decrease in blood glucose levels at 12 hours interval 
compared to that at 8 hours interval (p<0.05) and highly 
significant increase at 24 hours interval compared to that 
at 12 hours interval (p<0.001). 
 
Table I: Blood glucose levels after oral administration of crude 
extract of Caralluma tuberculata, Metformin and 2% Gum 
tragacanth in non-diabetic rabbits (n=21) 
Time 
interval 
Crude extract 
200mg/kg 
body weight 
500 mg/kg 
body 
weight 
20 ml 
(Hours) Caralluma 
tuberculate 
A1; (n=07) 
Metformin 
B1; (n=07) 
2% Gum 
tragacanth 
C1; (n=07) 
 Blood glucose 
(mg/dl) 
mean±SD 
Blood 
glucose 
(mg/dl) 
mean±SD 
Blood glucose 
(mg/dl) 
mean±SD 
0 104.33  1.33 92.16±0.83 94.17±0.60 
2 79.67 ± 2.96 82.00±0.96 94.00±0.58 
4 73.17 ± 2.64 72.50±1.31 94.33±0.81 
8 80.33 ± 2.23 79.66±1.76 93.50±0.67 
12 72.50 ± 0.88 87.16±0.75 91.67±0.50 
24 99.50 ± 1.61 92.00±0.57 92.50±1.05 
 
Table II: Blood glucose levels after oral administration of crude 
extract of Caralluma tuberculata (capsule form), Metformin and 
2% Gum tragacanth in diabetic rabbits (n=21) 
Time 
interval 
Crude extract 
200mg/kg 
body weight 
(Capsule form) 
500 mg/kg 
body weight 
 
20 ml 
(Hours) Caralluma 
tuberculate 
A2;(n=07) 
Metformin 
B2;(n=07) 
2% Gum 
tragacanth 
C2;(n=07) 
 Blood glucose 
(mg/dl) 
mean±SD 
Blood glucose 
(mg/dl) 
mean±SD 
Blood glucose 
(mg/dl) 
mean±SD 
0 318.16 ± 2.05 335.16 ± 3.04 309.00 ± 1.62 
2 268.00 ± 2.61 318.50 ± 2.96 309.66 ± 1.78 
4 263.00 ± 1.24 306.50 ± 1.65 309.00 ± 0.89 
8 269.33 ± 1.97 322.66 ± 3.08 309.16 ± 3.25 
12 260.33 ± 1.50 327.00 ± 2.50 312.00 ± 2.85 
24 287.83 ± 3.52 340.80 ± 3.63 310.33 ± 2.50 
                           J Islamabad Med Dental Coll 2019 37 
In comparison with metformin, capsule form of Caralluma 
crude extract showed significantly low mean blood 
glucose levels at 2 hours interval (p<0.001), 4 hours 
interval (p<0.001), 8 hours interval (p<0.001), 12 hours 
interval (p<0.001) and 24 hours interval (p<0.001). Oral 
administration of 2% gum tragacanth did not produce any 
appreciable decrease in blood glucose levels. 
 
After oral administration of CCl4 fraction of Caralluma in 
capsule, blood glucose levels dropped markedly at 2 
hours interval as compared to zero hour (p<0.001). But 
increase in mean blood glucose levels was observed at 8, 
12 and 24 hours. In comparison with metformin and 2% 
gum tragacanth, CCl4 fraction of Caralluma significantly 
lowered the blood glucose levels at 2 hours interval 
(p<0.001); 4 hours interval (p<0.001); 8 hours intervals 
(p<0.001); 12 hours intervals (p<0.001) and 24 hours 
intervals (p<0.001) (Table III). 
 
Table IV shows that CCl4 fraction of Caralluma in soy 
bean cooking oil caused significant reduction in blood 
glucose levels at 2, 4, 8, 12- and 24-hours intervals 
(p<0.001). There was significant difference in blood 
glucose levels in all groups at 4 hours interval compared 
to that at 2 hours interval (p<0.05). No significant increase 
in comparison at 4 hours vs. 8 hours (p=0.2); 8 hours vs 
12 hours (p=0.2) and 12 hours vs 24 hours (p=0.2) was 
observed in groups A4, B4 and C4. After treatment with 
20 ml cooking oil, no appreciable difference in mean 
blood glucose levels was observed. This experiment was 
maintained as control against treatment groups. 
 
Table III: Blood glucose levels after oral administration of 
CCl4 fractions of Caralluma tuberculata (capsule form), 
Metformin and 2% Gum tragacanth in diabetic rabbits (n=21) 
Time 
interval 
CCl4 fraction 
100mg/kg body 
weight 
(capsule form) 
500 mg/kg 
body weight 
 
20 ml 
(Hours) Caralluma 
tuberculate 
A3; (n=07) 
Metformin 
B3; (n=07) 
2% Gum 
tragacanth 
C3; (n=07) 
 Blood glucose 
(mg/dl) 
mean±SD 
Blood 
glucose 
(mg/dl) 
mean±SD 
Blood glucose 
(mg/dl) 
mean±SD 
0 309.50±1.38 335.16±3.04 309.00±1.62 
2 194.16±2.49 318.50±2.96 309.66±1.78 
4 184.16±3.73 306.50±1.65 309.00±0.89 
8 207.67±3.68 322.66±3.08 309.16 ± 3.25 
12 206.67±2.59 327.00±2.50 312.00 ± 2.85 
24 257.33±3.66 340.80±3.63 310.33 ± 2.50 
Table IV: Blood Glucose levels after oral administration of 
CCl4 fractions of Caralluma tuberculata (in cooking oil), 
Metformin and 20ml Soybean cooking oil as control in 
diabetic rabbits (n=21) 
Time 
interval 
CCl4 fraction 
100mg/kg body 
weight 
(In cooking oil) 
500 mg/kg 
body 
weight 
 
20 ml 
(Hours) Caralluma tuberculate 
A4; (n=07) 
Metformin 
B4; (n=07) 
Soy Bean 
cooking oil 
C4; (n=07) 
 Blood glucose (mg/dl) 
mean±SD 
Blood 
glucose 
(mg/dl) 
mean±SD 
Blood 
glucose 
(mg/dl) 
mean±SD 
0 287.55±1.96 335.16±3.04 301.00±2.08 
2 142.33±1.74 318.50±2.96 301.00±2.35 
4 151.33±2.26 306.50±1.65 302.66±3.48 
8 153.16±3.13 322.66±3.08 301.16±1.58 
12 158.00±2.80 327.00±2.50 303.16±2.24 
24 164.66±3.23 340.80±3.63 303.16±2.24 
 
It is worth mentioning here that from data given in Table 
III and IV, it is also observed that Caralluma tuberculata 
reduced blood glucose levels more efficiently when 
administered in cooking oil than in capsule form i.e. at 2, 
4, 8, 12- and 24-hours interval (p<0.001). 
 
D i s c u s s i o n  
In the present study, experimentation was done on 
different forms of Caralluma tuberculata i.e. crude extract 
and carbon tetrachloride fractions (CCl4) in both capsule 
and in cooking oil to find out the form in which it is more 
effective as hypoglycaemic agent. When crude extract of 
Carallumain in a dose of 200mg/kg body weight was 
administered in capsule form to diabetic rabbits, it caused 
highly significant reduction in blood glucose level after 2 
hours of treatment, which continued up to 12 hours. 
Whereas, when carbon tetrachloride (CCl4) fraction of 
Caralluma (100mg/kg body weight) in capsule form was 
administered, highly significant reduction in blood glucose 
level was seen from 2 hours after treatment till 24 hours. 
Carbon tetrachloride (CCl4) fraction of Caralluma 
(100mg/kg body weight) in cooking oil was also 
administered to diabetic rabbits. Beside significant 
reduction (p<0.001) in blood glucose levels, it was found 
that Caralluma tuberculata administered in cooking oil 
reduced blood glucose levels more than that administered 
in capsule form. 
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Unlike other studies, we used carbon tetrachloride fraction 
in capsule and cooking oil forms to compare their efficacy. 
The reported information regarding effects of medicinal 
plants in developing hypoglycaemia was observed at 
maximum 6 hours after administration of dose. In our 
study, strategy was adopted to evaluate effect after two 
hours of administration of dose and again after 4, 8, 12 
and 24 hours. It was aimed to see how long the dose 
effect of Caralluma sustains on blood glucose level. As far 
as the underlying mechanism for hypoglycaemia is 
concerned, it is deduced from various studies that this 
plant might contain multiple hypoglycaemic constituents, 
causing the release of insulin by stimulating beta cells and 
hence resulting in significant drop in blood glucose levels. 
Moreover, they may also have insulin like orally active 
substance, as Momordica charantia vegetable. 16 
 
In addition, drugs such as biguanides are known to 
produce hypoglycaemia by decreasing gluconeogenesis 
and promoting glycolysis.17 Biguanides prevent 
hypoglycaemia in normal individuals by balancing the 
increased peripheral glucose utilization and additional 
glucose output of hepatocytes. So, it is suggested that 
Caralluma may contain specific constituents, which cause 
hypoglycaemia either by increasing the insulin secretion 
or mimicking insulin action.18 Different substances, like 
anterior and posterior pituitary hormones, prostaglandins, 
corticosteroids etc and plants like Trigonella foenum 
produces hypoglycaemia by different means and 
mechanisms.19 Therefore, establishment of detailed 
phytochemical and pharmacological profile of this plant is 
necessary to identify the exact underlying mechanism of 
hypoglycaemia. 
 
C o n c l u s i o n  
Caralluma tuberculata lowered the blood glucose levels in 
mammalian model of rabbits and turned out to be more 
effective when taken with cooking oil. However, the 
efficacy of herbal medications needs to be further 
evaluated by well designed, controlled clinical studies. 
 
 
 
R e c o m m e n d a t i o n s  
1. Conduct Randomized Controlled Trial to establish 
efficacy and safety of Caralluma tuberculata as an oral 
hypoglycemic agent in diabetic patients 
2. The possible toxicity of the crude and CCl4 extracts of 
Caralluma tuberculata should be investigated. 
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